Form 4 for CBIO CRESCENT BIOPHARMA, INC.
Accepted 2023-05-09 00:00:00 ET · period of report 2023-05-08 · accession 0001209191-23-028305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-09 | 2023-05-08 | CBIO | Johnson Bruce S | SVP, Chief Commercial Off | P - Purchase | $1.57 | +13.5K | 139.0K | +11% | +$21.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-08 | P | A | 13,500 | $1.57 | 138,980 | D | — | — |